Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Clinical Evaluation of Hemospray: Hemostasis of Active GI Luminal Tract Bleeding

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01306864

Acronym

HALT

Enrollment

Registered

2011-03-02

Start date

2011-12-31

Completion date

2017-05-29

Last updated

2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding Peptic Ulcers

Keywords

Endoscopic Hemostasis, Peptic Ulcer, Recurrent Bleeding, Injection Therapy, Thermal Probe

Brief summary

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Interventions

DEVICEHemospray Kit

Hemostasis of Arterial GI Bleeding

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Bleeding peptic ulcer

Exclusion criteria

* Patient is: \< 18 years of age * Patient is unable to consent * Patient is contraindicated to undergo endoscopy * Patient has: coagulopathy, altered post surgical anatomy of the stomach, previously placed intrahepatic portosystemic shunt * Patient is pregnant or lactating * Patinet has an INR \> 2.5

Design outcomes

Primary

Measure	Time frame
Proportion of patients with further bleed	72 Hours

Secondary

Measure	Time frame
Proportion of patients with initial hemostasis	At the conclusion of the index procedure

Countries

Canada, Hong Kong, Netherlands, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026